"indian-immunologicals"

IL quickly responded to the nation’s call and the request of the Central Government, to partner with Bharat Biotech International Limited (BBIL) in April 2021 to produce a Covaxin drug substance.

Output of Covaxin drug substance will be adequate for 3 to 4 million doses a month and from December it will increase to 10 million doses a month

Task Force also discussed with them various alternatives to drugs that are in high demand like Remdesivir

Hyderabad-headquartered biologicals company setting up new viral antigen plant at Karkapatla in Telangana to cater to viral vaccines and opens new sterile filling facility